Big Move For Rubius Therapeutics, Inc.
Fri, Dec 08, 2023 at 07:37 PM
Rubius Therapeutics, Inc. (RUBY:NASDAQ) rocketted at $0.03, representing a gain of 56.3%. On Fri, Dec 08, 2023, RUBY:NASDAQ touched a New 2-Week High of $0.03. From Fri, Nov 24, 2023, the stock recorded 10.00% Up Days and 9.09% Green Days
About Rubius Therapeutics, Inc. (RUBY:NASDAQ)
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 400%
- MBIA Inc. (MBI:NYSE), 81.84%
- Intensity Therapeutics Inc. (INTS:NASDAQ), 63.81%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 56.25%
- Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 45.48%
- Assure Holdings Corp. (IONM:NASDAQ), 34.7%
- Statera Biopharma Inc. (STAB:NASDAQ), 33.33%
- ALX Oncology Holdings Inc. (ALXO:NASDAQ), 32.54%
- Azitra Inc (AZTR:NYSEMKT), 28.57%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 27.64%